Brentuximab Intravenous and Hylenex Recombinant
Determining the interaction of Brentuximab Intravenous and Hylenex Recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab vedotin, Brentuximab Vedotin
Generic Name: hyaluronidase
Brand name: Amphadase, Hylenex, Vitrase, Wydase, Hydase
Synonyms: Hyaluronidase (injection), Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab Intravenous-Hylorel
- Brentuximab Intravenous-Hymovis
- Brentuximab Intravenous-Hyolev MB
- Brentuximab Intravenous-Hyolev MB Tablets
- Brentuximab Intravenous-HyoMax
- Brentuximab Intravenous-HyoMax-DT
- Hylenex Recombinant-Brentuximab vedotin
- Hylenex Recombinant-Breo Ellipta
- Hylenex Recombinant-Brethine
- Hylenex Recombinant-Brethine Subcutaneous
- Hylenex Recombinant-Bretylium
- Hylenex Recombinant-Bretylium Injection